Ȩ Ä«Å×°í¸® ¸ÂÃãÇü½ÃÀåÁ¶»ç ±¹Á¦ÄÁÆÛ·±½º ±Û·Î¹ú ÆÄÆ®³Ê ¸ÞÀϸµ ¼­ºñ½º ȸ»ç¼Ò°³È¸»ç¼Ò°³ Contact Us
English Japaness Chinese
Ä«Å×°í¸®
¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö (1468)
°Ô³ð â¾à (202)
¸ÂÃãÇüÀÇ·á (54)
¹ÙÀÌ¿À¸¶Ä¿ (154)
¹ÙÀÌ¿À¸ÅÆ®¸®¾ó (55)
¹ÙÀÌ¿ÀÀåºñ (323)
ºÐÀÚÇ¥ÀûÄ¡·á(MTT) (53)
À¯ÀüÀÚ Ä¡·á/RNAi (100)
Àç»ýÀÇÇÐ (125)
Ç×ü/¸é¿ª (187)
Áö¿ªº°°Ë»ö
ÃâÆÇ»ç¿¡¼­ ã±â

¹ÙÀÌ¿ÀÀåºñ ½ÃÀåÁ¶»çº¸°í¼­

¹ÙÀÌ¿ÀÀåºñ ½ÃÀåÀ» Á¶»ç ºÐ¼®ÇÑ ÀÚ·á·Î ½ÃÀå ±Ô¸ð, »ê¾÷ ºÐ¼®, ÇâÈÄ ½ÃÀå ¿¹Ãø µîÀÇ ³»¿ëÀ» ´Ù·ç°í ÀÖ½À´Ï´Ù.
º¸°í¼­¿¡ µû¶ó¼­ ÁÖ¿ä ±â¾÷ ºÐ¼®, °æÀïȯ°æ ºÐ¼®, ¿¬±¸°³¹ß ÇöȲ, ¿µ¾÷ Àü·«, ±â¾÷ Á¦ÈÞ ÇöȲÀ» Æ÷ÇÔÇÏ´Â °æ¿ìµµ ÀÖ½À´Ï´Ù.

»ó¼¼ºÐ·ù
Á¦¸ñ°Ë»ö
1 - 25 ¸®ºä (Àüü£º 320 °Ç) Á¤·Ä Ç¥½Ã °Ç¼ö
2012 Protein Electrophoresis & Western Analysis Series 1 - Life Science Dashboard
»ùÇÃ
»óǰÄÚµå :219518
ºÏ¹Ì ¹× À¯·´ °úÇÐÀÚ¸¦ ´ë»óÀ¸·Î ½Ç½ÃÇÑ Á¶»ç¸¦ ¹ÙÅÁÀ¸·Î, ´Ü¹éÁú Àü±â¿µµ¿ ¹× ¿þ½ºÅÏ ºÐ¼®(Protein Electrophoresis & Western Analysis) Á¦Ç° À̿뿡 °üÇÑ °¢Á¾ ÁöÇ¥¸¦ Á¶»çÇϰí, ½ÃÀå±Ô¸ð, Á¦Ç° ÀÌ¿ë »óȲ, Á¦Ç°¿¡ ´ëÇÑ ¸¸Á·µµ, Á¦Ç° ¼±Á¤ ÀÇ»ç°áÁ¤¿¡ ¹ÌÄ¡´Â ¿µÇâ¿äÀÎ µîÀ» ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 3,975
¹ßÇàÀÏ 2012³â 01¿ù
¸®¼­Ä¡»ç Percepta Associates Inc.
ÆäÀÌÁö¼ö  
Emerging Special Hematology Tests and Flow Cytometry Applications
»ùÇÃ
»óǰÄÚµå :228247
Ư¼ö Ç÷¾×°Ë»ç ¹× À¯¼¼Æ÷ºÐ¼®±â(Special Hematology Tests and Flow Cytometry)ÀÇ ÀÓ»óÀûÀÎ Á߿伺°ú ½ÃÀå ¿ä±¸¿¡ ´ëÇØ ºÐ¼®Çϰí, °ü·Ã ±â¾÷ÀÌ ÆÇ¸ÅÇϰí ÀÖ´Â °ü·Ã ±â¼ú ¹× Á¦Ç°¿¡ °üÇÑ Á¤º¸¸¦ ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 1,850
¹ßÇàÀÏ 2012³â 01¿ù
¸®¼­Ä¡»ç Venture Planning Group
ÆäÀÌÁö¼ö  
Future Japanese Hematology and Flow Cytometry Markets
»ùÇÃ
»óǰÄÚµå :228246
ÀϺ»ÀÇ Ç÷¾×°Ë»ç(Hematology) ¹× À¯¼¼Æ÷ºÐ¼®±â(Flow Cytometry) ½ÃÀåÀ» ºÐ¼®Çϰí, ¼¼°è Àüü ½ÃÀå°ú ±â¼ú Ãֽе¿Çâ, ÀϺ» ½ÃÀå ÇöȲ°ú ÇâÈÄ ¿¹Ãø, ÇâÈÄ ½ÃÀå ¼ºÀå ±âȸ, ½ÃÀå ÃßÁø Àü·«°ú À庮, ±â¾÷ °³¿ä µîÀÇ Á¤º¸¸¦ ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 7,800
¹ßÇàÀÏ 2012³â 01¿ù
¸®¼­Ä¡»ç Venture Planning Group
ÆäÀÌÁö¼ö  
»ùÇÃ
»óǰÄÚµå :228217
BRICS ±¹°¡(ºê¶óÁú, ·¯½Ã¾Æ, Àεµ, Áß±¹, ³²¾ÆÇÁ¸®Ä«°øÈ­±¹)ÀÇ À¯ÀüÀÚ °Ë»ç(Genetic Testing) °ü·Ã ½ÃÀåÀ» ºÐ¼®Çϰí, 5°³±¹ Àüü ÆÇ¸Å ¸ÅÃâ°ú ½ÃÀå Á¡À¯À², ±¹°¡º° ½ÃÀå ¸ÅÃâ(½ÃÀå Àüü ¹× °¢ ºÎ¹®)°ú ±â¾÷ Á¡À¯À², ÁÖ¿ä ±â¾÷ °³¿ä¿Í ½ÃÀå Á¡À¯À² µîÀÇ Á¤º¸¸¦ ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 2,500
¹ßÇàÀÏ 2012³â 01¿ù
¸®¼­Ä¡»ç GlobalData
ÆäÀÌÁö¼ö Pages: 112
High-Content Analysis: Technologies, Applications, and Market Dynamics
»ùÇÃ
»óǰÄÚµå :228355
ÇÏÀÌÄÁÅÙÆ® ºÐ¼®(HCA : High-Content Analysis) ±â¼ú, ¿ëµµ, ½ÃÀå ¹ßÀü »óȲ¸¦ Á¶»ç ºÐ¼®Çϰí, HTS ¹× HCS·ÎºÎÅÍÀÇ ¹ßÀü »óȲ, HCA ½ÇÇö ±â¼ú°ú ÇöÀç À̿밡´ÉÇÑ ½Ã½ºÅÛ °³¿ä, HCA ÀÌ¿ë ºÐ¾ß¿Í ¿ëµµ, °æÀï ±¸µµ°ú ÁÖ¿ä °Å·¡/°è¾à ºÐ¼®, HCA »ç¿ëÀÚÀÇ ÀÌ¿ë µ¿Çâ Á¶»ç, Àü¹®°¡ ÀÎÅÍºä µîÀ» ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 2,495
¹ßÇàÀÏ 2011³â 12¿ù
¸®¼­Ä¡»ç Insight Pharma Reports
ÆäÀÌÁö¼ö  
European Molecular Diagnostics Markets
»ùÇÃ
»óǰÄÚµå :227473
À¯·´ ºÐÀÚ Áø´Ü ½ÃÀåÀÇ ÇöȲ°ú Àü¸Á¿¡ ´ëÇØ Á¶»çºÐ¼®ÇßÀ¸¸ç, ÀÇ·á ºÎ¹® ¹× ÁÖ¿ä Áö¿ª/±¹°¡º° ½ÃÀå ºÐ¼®, ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ¹× ÀúÇØ¿äÀÎ, ÃÖÁ¾»ç¿ëÀÚ ºÐ¼®, °æÀï ȯ°æ, ½ÃÀå Á¡À¯À² µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 6,000
¹ßÇàÀÏ 2011³â 12¿ù
¸®¼­Ä¡»ç Frost & Sullivan
ÆäÀÌÁö¼ö  
Strategic Analysis of the European Stem Cell Research Tools Market
»ùÇÃ
»óǰÄÚµå :227461
À¯·´ÀÇ Áٱ⼼Æ÷ ¿¬±¸¿ë Åø(Stem Cell Research Tools) ½ÃÀå ÇöȲ°ú Àü¸Á¿¡ ´ëÇØ Á¶»ç ºÐ¼®Çϰí, °¢Á¾ ÅøÀÇ Á¾·ù¿Í °³¿ä, ÃÖÁ¾ »ç¿ëÀÚ¿Í ÀÌ¿ë µ¿Çâ, ¸ÅÃâ ¿¹Ãø°ú Á¦Ç° ±¸ºÐº° ºÐ¼®, ½ÃÀå ¼ºÀå¿¡ ´ëÇÑ °¢Á¾ ¿µÇâ¿äÀÎ, ÁÖ¿ä ±â¾÷°ú °æÀï ȯ°æ µîÀ» ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 6,500
¹ßÇàÀÏ 2011³â 12¿ù
¸®¼­Ä¡»ç Frost & Sullivan
ÆäÀÌÁö¼ö  
Frost & Sullivan 2011 Survey of Sequencing Technologies: Instrument Adoption on the Rise as Affordable Systems Enter the Market
»ùÇÃ
»óǰÄÚµå :228274
"Lab Manager Magazine" ÆíÁýºÎ¿Í °øµ¿À¸·Î, Lab Manager Magazine µ¶ÀÚ 79¸íÀ» ´ë»óÀ¸·Î ½Ç½ÃÇÑ ¾ÓÄÉÀÌÆ® Á¶»ç °á°ú¸¦ Á¤¸®Çϰí, ÇöÀç ¹× ÇâÈÄ ½ÃÄö½Ì(Sequencing) ±â¼ú µµÀÔ °¡´É¼º, ºê·£µå ¹× Àåºñ ¼±È£, ¾Æ¿ô¼Ò½Ì, ¿¬±¸ ¿¹»ê, Ȱ¿ë°ú ÀÌ¿ë »óȲ, °úÁ¦ µî¿¡ ´ëÇÑ Á¶»ç ºÐ¼® °á°ú¸¦ ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 10,000
¹ßÇàÀÏ 2011³â 12¿ù
¸®¼­Ä¡»ç Frost & Sullivan
ÆäÀÌÁö¼ö 62 Pages
World Molecular Diagnostics Market: Growth Opportunities, Business Expansion Strategies, Entry Barriers and Risks
»ùÇÃ
»óǰÄÚµå :225055
¼¼°è ºÐÀÚÁø´Ü(Molecular Diagnostics) °ü·Ã ½ÃÀåÀÇ ½ÅÁ¦Ç°(Áø´Ü Àåºñ, ¼Ò¸ðǰ, º¸Á¶ Á¦Ç°) °³¹ß ±âȸ¿¡ ´ëÇØ ºÐ¼®Çϰí, ÃÑ 60°³ ǰ¸ñ ÀÌ»óÀÇ Á¦Ç°¿¡ ´ëÇØ ÀÌ»óÀûÀÎ Á¦Ç° ¸ðµ¨(¿¹Ãø °¡°Ý, °Ë»ç Ư¼º µîÀÇ Á¤º¸ Æ÷ÇÔ)À» Á¦½ÃÇØ µå¸®¸ç, °ø±Þ¾÷ü¸¦ À§ÇÑ ´ëüÀû Á¦Ç° º¸±Þ Àü·« Á¦¾È µîÀ» ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 850
¹ßÇàÀÏ 2011³â 12¿ù
¸®¼­Ä¡»ç Venture Planning Group
ÆäÀÌÁö¼ö  
Emerging Molecular Diagnostic Applications: Forensics, Paternity, Disease Susceptibility
»ùÇÃ
»óǰÄÚµå :225054
¹ýÀÇÇÐ °Ë»ç, Ä£ÀÚ°¨º°, À̺´¼º ¹× ±âŸ ºÐÀÚ Áø´Ü °Ë»ç µî ÁÖ¿ä ºÐÀÚ Áø´Ü °Ë»çÀÇ ÀÓ»óÀû À¯ÀǼº°ú ½ÃÀåÀÇ ¼ö¿ä¿¡ ´ëÇØ °ËÁõÇϰí, ºÐÀÚ Áø´ÜÀÇ ½Å±â¼ú°ú ½ÅÁ¦Ç°À» °³¹ß/ÆÇ¸ÅÇϰí ÀÖ´Â ±â¾÷ ¸®½ºÆ®¸¦ Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 850
¹ßÇàÀÏ 2011³â 12¿ù
¸®¼­Ä¡»ç Venture Planning Group
ÆäÀÌÁö¼ö  
World Molecular Diagnostics Market Key Players: Strategic Assessments of Major Suppliers and Emerging Market Entrants
»ùÇÃ
»óǰÄÚµå :225053
¼¼°è ºÐÀÚÁø´Ü(Molecular Diagnostics) ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷ ¹× ½ÅÈï±â¾÷ÀÇ Àü·«À» Æò°¡ÇÏ¿© ±× °á°ú¸¦ ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 2,500
¹ßÇàÀÏ 2011³â 12¿ù
¸®¼­Ä¡»ç Venture Planning Group
ÆäÀÌÁö¼ö  
Emerging Cancer Molecular Diagnostic Tests
»ùÇÃ
»óǰÄÚµå :225052
ÁÖ¿ä Á¾¾ç ¸¶Ä¿ÀÇ ÀÓ»óÀû ÀÇÀÇ, ½ÃÀå ¿ä±¸ °³¿ä, ¾Ï °Ë»ç ºÐÀÚÁø´Ü(Molecular Diagnostic) ±â¼ú, Á¦Ç° °³¹ß ¹× ¸¶ÄÉÆÃ ±â¾÷ °³¿ä¸¦ ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 1,450
¹ßÇàÀÏ 2011³â 12¿ù
¸®¼­Ä¡»ç Venture Planning Group
ÆäÀÌÁö¼ö  
World Molecular Diagnostics Market: Facilities, Test Volumes, and Sales Forecasts by Country
»ùÇÃ
»óǰÄÚµå :225051
¼¼°è °¢±¹ÀÇ ºÐÀÚÁø´Ü(Molecular Diagnostics) ½ÃÀåÀ» ºÐ¼®Çϰí, DNA ¿°±â¹è¿­ °áÁ¤ ¹× ºÐÀÚÁø´Ü °Ë»ç¸¦ ½Ç½ÃÇϰí ÀÖ´Â ½Ã¼³ ¿¹Ãø, ÇâÈÄ 5-10³â°£ÀÇ °Ë»ç °Ç¼ö, Áø´Ü ¸ÅÃâ ¿¹Ãø Á¤º¸¸¦ ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 1,850
¹ßÇàÀÏ 2011³â 12¿ù
¸®¼­Ä¡»ç Venture Planning Group
ÆäÀÌÁö¼ö  
Emerging Coagulation Tests and Suppliers Developing New Technologies
»ùÇÃ
»óǰÄÚµå :225041
ÁÖ¿ä Ç÷¾× ÀÀ°í °Ë»ç(Coagulation Tests)ÀÇ ÀÓ»óÀû ÀÇÀÇ¿Í ½ÃÀå ¿ä±¸¸¦ Á¶»çÇϰí, »õ·Î¿î Ç÷¾× ÀÀ°í °Ë»ç ±â¼ú°ú Á¦Ç°À» °³¹ßÇϰí ÀÖ´Â ±â¾÷ ¸ñ·ÏÀ» ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 1,850
¹ßÇàÀÏ 2011³â 12¿ù
¸®¼­Ä¡»ç Venture Planning Group
ÆäÀÌÁö¼ö  
World Coagulation Market Key Players: Strategic Assessments of Major Suppliers and Emerging Market Entrants
»ùÇÃ
»óǰÄÚµå :225040
¼¼°è Ç÷¾× ÀÀ°í(Coagulation) ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷ ¹× ½ÅÈï ½ÃÀå Àü·« Æò°¡¸¦ ºÐ¼®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 2,500
¹ßÇàÀÏ 2011³â 12¿ù
¸®¼­Ä¡»ç Venture Planning Group
ÆäÀÌÁö¼ö  
Emerging Coagulation Testing Technologies and Market Applications
»ùÇÃ
»óǰÄÚµå :225039
ÀÀ°í °Ë»ç ±â¼ú¿¡ ´ëÇØ Á¶»çºÐ¼®ÇßÀ¸¸ç, ¹ß»ö ±âÁú, ¸ð³ëŬ·Î³Î Ç×ü¿Í Æú¸®Å¬·Î³Î Ç×ü, ¸é¿ªÃøÁ¤¹ý µî ÇöÀç ¹× ½Å±Ô ÀÀ°í °Ë»ç ±â¼ú°ú ÀáÀçÀûÀÎ ½ÃÀå¿¡¼­ÀÇ ÀÀ¿ë¿¡ ´ëÇØ ºÐ¼®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 1,850
¹ßÇàÀÏ 2011³â 12¿ù
¸®¼­Ä¡»ç Venture Planning Group
ÆäÀÌÁö¼ö  
Emerging Clinical Chemistry And Immunodiagnostic Technologies
»ùÇÃ
»óǰÄÚµå :225038
ÀÓ»óÈ­ÇÐ(Clinical Chemistry) ¹× ¸é¿ªÁø´Ü(Immunodiagnostic) ±â¼ú¿¡ ´ëÇØ Á¶»çÇϰí, IT, ºÐÀÚÁø´Ü, ¸é¿ªÃøÁ¤¹ý(Immunoassays), µå¶óÀÌ Äɹ̽ºÆ®¸®(Dry Chemistry) µî ½ÅÈï ±â¼ú°ú ±× ÀáÀçÀû ½ÃÀå¿¡¼­ÀÇ ÀÀ¿ë¿¡ ´ëÇØ ºÐ¼®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 1,500
¹ßÇàÀÏ 2011³â 12¿ù
¸®¼­Ä¡»ç Venture Planning Group
ÆäÀÌÁö¼ö  
Emerging Chemistry and Immunodiagnostic Tests and Companies Developing New Technologies
»ùÇÃ
»óǰÄÚµå :225036
ÀÓ»óÈ­Çа˻ç(Chemistry Tests) ¹× Áø´Ü¸é¿ª°Ë»ç(Immunodiagnostic Tests) ½ÃÀå¿¡ ´ëÇØ Á¶»ç ºÐ¼®Çϰí, È­Çа˻ç, TDM, ³»ºÐºñ ±â´É °Ë»ç, Á¾¾ç ¸¶Ä¿, ¸é¿ª ´Ü¹é °Ë»ç, ¾à¹° ³²¿ë °Ë»ç µî ÁÖ¿ä °Ë»çÀÇ ÀÓ»óÀû ÀÇÀÇ¿Í ½ÃÀå ¼ö¿ä ºÐ¼®, ½Å±â¼ú°ú ½ÅÁ¦Ç°À» °³¹ß, ÆÇ¸ÅÇϰí ÀÖ´Â ±â¾÷ ¸®½ºÆ® Á¤º¸¸¦ ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 3,400
¹ßÇàÀÏ 2011³â 12¿ù
¸®¼­Ä¡»ç Venture Planning Group
ÆäÀÌÁö¼ö  
World Clinical Chemistry and Immunodiagnostics Market Key Players: Strategic Assessments of Major Suppliers and Emerging Market Entrants
»ùÇÃ
»óǰÄÚµå :225035
¼¼°è ÀÓ»óÈ­ÇÐ(Clinical Chemistry) ¹× ¸é¿ªÁø´Ü(Immunodiagnostics) ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷ ¹× ½ÅÈï ½ÃÀå Àü·« Æò°¡¸¦ ºÐ¼®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 1,850
¹ßÇàÀÏ 2011³â 12¿ù
¸®¼­Ä¡»ç Venture Planning Group
ÆäÀÌÁö¼ö  
Future Clinical Chemistry Market: US, Europe, Japan
»ùÇÃ
»óǰÄÚµå :225031
¼¼°è ÁÖ¿ä ±¹°¡(¹Ì±¹, ¿µ±¹, µ¶ÀÏ, ÇÁ¶û½º, ÀÌÅ»¸®¾Æ, ½ºÆäÀÎ, ÀϺ»)ÀÇ ÀÓ»óÈ­ÇÐ(Clinical Chemistry) °ü·Ã ½ÃÀåÀ» ºÐ¼®Çϰí, Ãֽбâ¼ú µ¿Çâ, ÇâÈÄ °¢±¹ÀÇ ½ÃÀå µ¿Çâ(½ÃÀå±Ô¸ð, ¸ÅÃâ¾×, ½ÃÀå Á¡À¯À² µî), ½ÃÀå °³¹ß Àü·«°ú À庮, ±â¾÷ °³¿ä µîÀÇ Á¤º¸¸¦ ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 12,500
¹ßÇàÀÏ 2011³â 12¿ù
¸®¼­Ä¡»ç Venture Planning Group
ÆäÀÌÁö¼ö  
Future Clinical Chemistry and Immunodiagnostics Markets: Facilities, Test Volumes, and Sales Forecasts by Country
»ùÇÃ
»óǰÄÚµå :225030
¼¼°è ¹× ÁÖ¿ä 7°³±¹ÀÇ ÀÓ»óÈ­ÇÐ(Clinical Chemistry) ¹× ¸é¿ªÁø´Ü(Immunodiagnostics) °ü·Ã ½ÃÀåÀ» ºÐ¼®Çϰí, Ãֽбâ¼ú µ¿Çâ, ÇâÈÄ 10³â°£ °¢±¹ÀÇ ½ÃÀå µ¿Çâ(½ÃÀå±Ô¸ð, ¸ÅÃâ¾×, ½ÃÀå Á¡À¯À² µî), ½ÃÀå °³¹ß Àü·«°ú À庮, ±â¾÷ °³¿ä µîÀÇ Á¤º¸¸¦ ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 1,650
¹ßÇàÀÏ 2011³â 12¿ù
¸®¼­Ä¡»ç Venture Planning Group
ÆäÀÌÁö¼ö  
»ùÇÃ
»óǰÄÚµå :225029
¼¼°è ¹× ÁÖ¿ä 7°³±¹ÀÇ ¼¼Æ÷ Ç¥¸é ¸¶Ä¿(Cell Surface Markers) °ü·Ã ½ÃÀåÀ» ºÐ¼®Çϰí, Ãֽбâ¼ú µ¿Çâ, ÇâÈÄ 5-10³â°£ °¢±¹ ½ÃÀå µ¿Çâ(½ÃÀå±Ô¸ð, ¸ÅÃâ¾×, ½ÃÀå Á¡À¯À² µî), ½ÃÀå °³¹ß Àü·«°ú À庮, ±â¾÷ °³¿ä µîÀÇ Á¤º¸¸¦ ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 4,750
¹ßÇàÀÏ 2011³â 12¿ù
¸®¼­Ä¡»ç Venture Planning Group
ÆäÀÌÁö¼ö  
Global PSA Testing Market: Growth Opportunities and Strategies
»ùÇÃ
»óǰÄÚµå :225028
¼¼°è ÁÖ¿ä ±¹°¡(¹Ì±¹, ¿µ±¹, µ¶ÀÏ, ÇÁ¶û½º, ÀÌÅ»¸®¾Æ, ½ºÆäÀÎ, ÀϺ»)ÀÇ Àü¸³¼±Æ¯ÀÌÇ׿ø(PSA) °Ë»ç °ü·Ã ½ÃÀåÀ» ºÐ¼®Çϰí, ÃֽŠÁø´Ü ±â¼ú µ¿Çâ, ÇâÈÄ 5-10³â°£ °¢±¹ ½ÃÀå µ¿Çâ(°Ë»ç °Ç¼ö, Áø´Ü ¸ÅÃâ µî), ÇâÈÄÀÇ ½ÃÀå Àü°³ Àü·«°ú Àå¾Ö¿äÀÎ, °¢ ±â¾÷ °³¿ä µîÀÇ Á¤º¸¸¦ ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 3,850
¹ßÇàÀÏ 2011³â 12¿ù
¸®¼­Ä¡»ç Venture Planning Group
ÆäÀÌÁö¼ö  
»ùÇÃ
»óǰÄÚµå :225027
¼¼°è ÁÖ¿ä ±¹°¡(¹Ì±¹, ¿µ±¹, µ¶ÀÏ, ÇÁ¶û½º, ÀÌÅ»¸®¾Æ, ½ºÆäÀÎ, ÀϺ»)ÀÇ ¼¼Æ÷µµ¸»°Ë»ç(Pap Smear) ¹× ÀÎÀ¯µÎÁ¾¹ÙÀÌ·¯½º(HPV) °Ë»ç °ü·Ã ½ÃÀåÀ» ºÐ¼®Çϰí, ÃֽŠÁø´Ü ±â¼ú µ¿Çâ, ÇâÈÄ 5-10³â°£ °¢±¹ ½ÃÀå µ¿Çâ(°Ë»ç °Ç¼ö, Áø´Ü ¸ÅÃâ µî), ÇâÈÄÀÇ ½ÃÀå Àü°³ Àü·«°ú Àå¾Ö¿äÀÎ, °¢ ±â¾÷ °³¿ä µîÀÇ Á¤º¸¸¦ ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 3,850
¹ßÇàÀÏ 2011³â 12¿ù
¸®¼­Ä¡»ç Venture Planning Group
ÆäÀÌÁö¼ö  
Global Prostatic Acid Phosphatase Testing Market: Growth Opportunities and Strategies
»ùÇÃ
»óǰÄÚµå :225026
¼¼°è ÁÖ¿ä ±¹°¡(¹Ì±¹, ¿µ±¹, µ¶ÀÏ, ÇÁ¶û½º, ÀÌÅ»¸®¾Æ, ½ºÆäÀÎ, ÀϺ»)ÀÇ Àü¸³¼±»êÀÎ»ê ºÐÇØÈ¿¼Ò(PAP, Prostatic Acid Phosphatase) °Ë»ç °ü·Ã ½ÃÀåÀ» ºÐ¼®Çϰí, ÃֽŠÁø´Ü ±â¼ú µ¿Çâ, ÇâÈÄ 5-10³â°£ °¢±¹ ½ÃÀå µ¿Çâ(°Ë»ç °Ç¼ö, Áø´Ü ¸ÅÃâ µî), ÇâÈÄÀÇ ½ÃÀå Àü°³ Àü·«°ú Àå¾Ö¿äÀÎ, °¢ ±â¾÷ °³¿ä µîÀÇ Á¤º¸¸¦ ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 3,850
¹ßÇàÀÏ 2011³â 12¿ù
¸®¼­Ä¡»ç Venture Planning Group
ÆäÀÌÁö¼ö